BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

695 related articles for article (PubMed ID: 27560278)

  • 1. Rhythm control in atrial fibrillation.
    Piccini JP; Fauchier L
    Lancet; 2016 Aug; 388(10046):829-40. PubMed ID: 27560278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemporary approach to electrical and pharmacological cardioversion of atrial fibrillation.
    Rajagopalan B; Curtis AB
    Postgrad Med; 2012 Nov; 124(6):26-35. PubMed ID: 23322136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into atrial fibrillation.
    Mischke K; Knackstedt C; Marx N; Vollmann D
    Minerva Med; 2013 Apr; 104(2):119-30. PubMed ID: 23514988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart Failure and Atrial Fibrillation.
    McCulloch B
    Crit Care Nurs Clin North Am; 2015 Dec; 27(4):427-38. PubMed ID: 26567489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial fibrillation: goals of therapy and management strategies to achieve the goals.
    Padanilam BJ; Prystowsky EN
    Med Clin North Am; 2008 Jan; 92(1):217-35, xii-xiii. PubMed ID: 18061006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulation in atrial fibrillation: a contemporary viewpoint.
    Wyse DG
    Heart Rhythm; 2007 Mar; 4(3 Suppl):S34-9. PubMed ID: 17336882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Atrial Fibrillation.
    Prystowsky EN; Padanilam BJ; Fogel RI
    JAMA; 2015 Jul; 314(3):278-88. PubMed ID: 26197188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delaying cardioversion following 4-week anticoagulation in case of persistent atrial fibrillation after a transcatheter ablation procedure to reduce silent cerebral thromboembolism: a single-center pilot study.
    Pianelli M; Scaglione M; Anselmino M; Caponi D; Garcia P; Cesarani F; Toso E; Raimondo C; Halimi F; Leclercq JF; Gaita F
    J Cardiovasc Med (Hagerstown); 2011 Nov; 12(11):785-9. PubMed ID: 21941200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial fibrillation: goals of therapy and management strategies to achieve the goals.
    Padanilam BJ; Prystowsky EN
    Cardiol Clin; 2009 Feb; 27(1):189-200, x. PubMed ID: 19111774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic management of atrial fibrillation: established and emerging options.
    Kalus JS
    J Manag Care Pharm; 2009 Aug; 15(6 Suppl B):S10-8. PubMed ID: 19678722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study.
    Opolski G; Torbicki A; Kosior DA; Szulc M; Wozakowska-Kaplon B; Kolodziej P; Achremczyk P;
    Chest; 2004 Aug; 126(2):476-86. PubMed ID: 15302734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving outcomes in patients with atrial fibrillation: rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial.
    Kirchhof P; Breithardt G; Camm AJ; Crijns HJ; Kuck KH; Vardas P; Wegscheider K
    Am Heart J; 2013 Sep; 166(3):442-8. PubMed ID: 24016492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controversies in atrial fibrillation.
    Nattel S; Opie LH
    Lancet; 2006 Jan; 367(9506):262-72. PubMed ID: 16427496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological therapy following catheter ablation of atrial fibrillation.
    Rordorf R; Savastano S; Gandolfi E; Vicentini A; Petracci B; Landolina M
    J Cardiovasc Med (Hagerstown); 2012 Jan; 13(1):9-15. PubMed ID: 22025202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Stroke and other thromboembolic complications of atrial fibrillation. Part VI. Choice of optimal approach and drugs for prevention of stroke].
    Preobrazhenskiĭ DV; Sidorenko BA; Kiktëv VG; Batyraliev TA; Pershukov IV
    Kardiologiia; 2005; 45(1):84-93. PubMed ID: 15699946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The implementation of a comprehensive clinical protocol improves long-term success after surgical treatment of atrial fibrillation.
    Ad N; Henry L; Hunt S; Stone L
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1146-52. PubMed ID: 20412955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risks and benefits of rate control versus maintenance of sinus rhythm.
    Saxonhouse SJ; Curtis AB
    Am J Cardiol; 2003 Mar; 91(6A):27D-32D. PubMed ID: 12670639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The RACE study in perspective of randomized studies on management of persistent atrial fibrillation.
    Hagens VE; Van Gelder IC; Crijns HJ;
    Card Electrophysiol Rev; 2003 Jun; 7(2):118-21. PubMed ID: 14618033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial fibrillation.
    Lip GY; Tse HF; Lane DA
    Lancet; 2012 Feb; 379(9816):648-61. PubMed ID: 22166900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of atrial fibrillation].
    Kirchhof P; Breithardt G
    Internist (Berl); 2007 Aug; 48(8):819-29; quiz 830-1. PubMed ID: 17632695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.